Skip to main content

MoneyWorks4Me

Denis Chem Lab - Quaterly Results

05 Nov 2026 Evaluate
The sales for the September 2026 quarter moved down to Rs. 393.50 millions as compared to Rs. 461.71 millions during the year-ago period.The Net Loss for the quarter ended September 2026 is Rs. -5.71 millions as compared to Net Profit of Rs. 22.12 millions of corresponding quarter ended September 2025Operating Profit reported a sharp decline to 10.71 millions from 49.12 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 393.50 461.71 -14.77 833.47 894.47 -6.82 1817.20 1733.00 4.86
Other Income 3.68 6.47 -43.12 8.18 9.47 -13.62 19.23 23.74 -19.00
PBIDT 10.71 49.12 -78.20 53.52 100.25 -46.61 195.71 184.83 5.89
Interest 1.66 2.34 -29.06 2.74 4.20 -34.76 8.41 5.10 64.90
PBDT 9.05 46.78 -80.65 50.78 96.05 -47.13 187.30 179.73 4.21
Depreciation 16.62 16.53 0.54 31.92 32.65 -2.24 68.36 68.61 -0.36
PBT -7.57 30.25 -125.02 18.86 63.40 -70.25 118.94 111.12 7.04
TAX -1.86 8.13 -122.88 4.13 16.54 -75.03 34.86 30.35 14.86
Deferred Tax -7.22 5.36 -234.70 -3.75 4.44 -184.46 -3.68 -8.98 -59.02
PAT -5.71 22.12 -125.81 14.73 46.86 -68.57 84.08 80.77 4.10
Equity 138.77 138.77 0.00 138.77 138.77 0.00 138.77 138.77 0.00
PBIDTM(%) 2.72 10.64 -74.42 6.42 11.21 -42.71 10.77 10.67 0.98
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..